Abstract Human regulatory T cells (T R ) cells have potential for the treatment of a variety of immune mediated diseases but the anergic phenotype of these cells makes them difficult to expand in vitro. We have examined the requirements for growth and cytokine expression from highly purified human T R cells, and correlated these findings with the signal transduction events of these cells. We demonstrate that these cells do not proliferate or secrete IL-10 even in the presence of high doses of IL-2. Stimulation with a superagonistic anti-CD28 antibody (clone 9.3) and IL-2 partially reversed the proliferative defect, and this correlated with reversal of the defective calcium mobilization in these cells. Dendritic cells were effective at promoting T R cell proliferation, and under these conditions the proliferative capacity of T R cells was comparable to conventional CD4 lymphocytes. Blocking TGF-β activity abrogated IL-10 expression from these cells, while addition of TGF-β resulted in IL-10 production. These data demonstrate that highly purified populations of T R cells are anergic even in the presence of high doses of IL-2. Furthermore, antigen presenting cells provide proper co-stimulation to overcome the anergic phenotype of T R cells, and under these conditions they are highly sensitive to IL-2. In addition, these data demonstrate for the first time that TGF-β is critical to enable human T R cells to express IL-10.
Introduction
T regulatory cells (T R ) are essential regulators of immune responses, as demonstrated by patients lacking T R cells due to mutations in the transcription factor Foxp3. These patients develop the fatal autoimmune disease X-linked syndrome of immune dysfunction, polyendocrinopathy, and enteropathy (IPEX) [1] [2] [3] [4] [5] . These patients exhibit a variety of autoimmune features from an early age, including diabetes mellitus and other endocrinopathies, inflammatory bowel disease, severe allergies and eczema. Defects in T R cells have been implicated in numerous immune mediated illnesses, including autoimmune diseases and graft versus host disease [6] . T R cells constitutively express the IL-2 receptor subunit CD25 implicating IL-2 in the function of T R cells. In support of this, we have described a patient lacking CD25 due to compound heterozygous gene mutations who expressed a disease very similar to patients with IPEX because of Foxp3 mutations [7] . T R cells suppress immune responses by a number of mechanisms, including CTLA-4 engagement of B7 molecules on target cells, surface expression of TGF-β [8] [9] [10] , cytotoxicity of target cells through the perforin/granzyme pathway [11] , and by the expression of immunosuppressive cytokines, including TGF-β, and IL-10 [12, 13] .
Given the central role T R cells play in immune regulation, there is considerable interest in developing these cells for immunotherapy [14] [15] [16] [17] [18] . One difficulty in utilizing these cells as a therapeutic agent is the relative small number of Foxp3 + T R cells in human peripheral blood, accounting for only 5-10 % of peripheral blood CD4 cells. It is important to note that CD25 is not specific for T R cells as activated lymphocytes also express this marker. Thus interpreting studies where T R cells have been isolated based on CD25 expression can be problematic. Finding ways to expand human T R cells would be beneficial, however, T R cells fail to proliferate in vitro in response to TCR activation [19] . One possible explanation of why these cells fail to grow under these conditions is that T R cells fail to express IL-2 upon TCR activation, and it has been shown that Foxp3 binds to the IL-2 promoter and blocks transcription of the IL-2 gene [20, 21] . In support of this notion, treatment of human CD25
+ cells with high doses of IL-2 has been reported to restore their growth [19] . We have previously shown that highly purified T R cells from human blood do not proliferate in response to activation with antibodies to CD3 and CD28 even in the presence of IL-2 [11] . These studies utilized only the highest 1-2 % of CD25 expressing CD4 + lymphocytes from human peripheral blood, a population that is highly enriched in T R cells. To better characterize the requirements for growth and IL-10 production from human T R cells, we utilized a strategy to isolate highly purified T R without other contaminating cell populations. Using this strategy, we performed a comprehensive analysis of the requirements for T R cells growth, cytokine expression, and the signal transduction events of these cells.
Materials and Methods
Reagents Antibodies to CD25 (clone M-A251), CD4 (clone OKT-4), CD28 (clone 28.2), CD45RA (clone UCHL1), CD45RO (MEM-S6) were purchased from BDBiosciences. CD14 antibody (clone TuK4) was purchased from Caltag. Foxp3 antibody was purchased from eBioscience (clone PCH101). Antibodies to CD3 (clone OKT3), CD14 (clone HB247), and CD28 (clone 9.3) were isolated from tissue culture supernatants by protein G isolation (ATCC). CD46 antibody (clone Tra-2-10) was a gift of Dr. John Atkinson (St Louis, MO). Goat anti-mouse Ig magnetic beads were produced as follows: 10 mg of 50 nm magnetic beads (fluidMAG-ARA) (Chemicell, Germany) were incubated with 40 mg of EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) (Sigma) and 40 mg NHS (Nhydroxysuccinimidyl (NHS) ester) (Sigma) in 25 mM MES (2-(N-morpholino)ethanesulfonic acid) (pH 6.0) for 30 min at room temperature. Beads were run on a magnetic column (Miltenyi) and washed with MES. Beads were then eluted with MES and incubated with 1 mg of goat anti-mouse antibody (Sigma) at 4°C rotating overnight. Goat-anti mouse conjugated beads were column purified, washed in storage buffer (0.1%BSA, 0.02 % sodium azide, and 10 mM Tris), and stored at 4°C until used.
Cell Isolations Peripheral blood mononuclear cells (PBMC) were isolated by density gradient centrifugation of peripheral blood from random blood donors using Ficoll-Paque (Amersham). PBMCs were stained with CD25-PE antibodies in buffer consisting of PBS, 2 % newborn calf serum, 2 mM EDTA, and 50 μg/ml of human immunoglobulin (Gammaguard, Baxter). Cells were washed with staining buffer and incubated with Goat anti-Mouse Ig coated magnetic beads for 30 min at room temperature. Cells were washed and purified on a magnetic column (Miltenyi). Eluted CD25 + cells were subsequently stained with a CD4 antibody, and sorted based on CD25 expression using a FACSAria cell sorter (BDBiosciences).
Monocytes were isolated from PBMCs using CD14 antibodies and goat anti-mouse IgG magnetic beads, followed by magnetic column isolation. The isolated population was then stained with CD14 Alexa-700 (clone TuK4, Invitrogen), then purified by cell sorting based on CD14 expression.
Generation of Immature and Matured Myeloid Dendritic
Cells Dendritic cells were generated from CD14 + monocytes isolated as described above by culturing for 4 days in 1000U/ml IL-4 and 50 ng/ml GM-CSF. These cells expressed high levels of HLA Class-II and CD86 (data not shown). Maturation of dendritic cells was induced by adding 300 ng/ml LPS for an additional 24-36 h as previously described.
T Cell Activation Assay Isolated cells were activated by plating on 96-well flat-bottom plates coated with 2.5 μg/ ml of purified antibody in PBS. Cells were cultured in RPMI-1640 (Hi-Clone) supplemented with 1 mM glutamine, 1 mM penicillin/streptomycin, 1 mM MEM and 10 mM sodium pyruvate along with 10 % FBS and 0.5 % β-mercaptoethanol (R10 media). Supernatants were removed 4 days later and IL-10 expression quantified by ELISA.
3 H-thymidine was added for an additional 16 h, and uptake of radioactivity was measured using a betaplate scintillation counter.
For studies with TGF-β and TGF neutralizing antibodies, cells were activated with CD3/CD28 antibody in R10 with IL-2 at 10 U/ml with or without added human TGF-β 1 (5 ng/ml). A pan-TGF blocking antibody (clone 1D11) was used at 100 μg/ml. After 3-4 days proliferation and IL-10 production was measured.
Elisa High protein binding plates (Polysorb, Nunc) were coated with an IL-10 capture antibody (clone JES5-2A5 BDBiosciences) in PBS at 5 μg/ml overnight at 4 C. Plates were washed with PBS plus 0.05 % Tween-20 (PBST) and blocked with 1 % BSA solution in PBST for 30 min at room temperature. Culture supernatants were added and incubated overnight at 4°C. Plates were then washed and a biotinylated anti-IL-10 antibody (clone JES5-16E3 EBiosciences) diluted 1:1000 in blocking buffer was incubated for 1-2 h at room temperature. Plates were washed, and Streptavidin-HRP (Pierce) diluted 1:10,000 in blocking buffer was added and incubated for 1 h at room temperature. Plates were then washed and developed using ABTS (Pierce) according to the manufacturer's instructions.
Flow Cytometric Intracellular Calcium Analysis Changes in intracellular calcium were measured by flow cytometry using Fluo-4AM (Invitrogen). Cells were washed and resuspended in R10 medium at a density of 5 × 10 6 /ml and warmed to 37°C for 15 min. Fluo-4AM was added at a final concentration of 2.5 μM. Cells were incubated at 37°C for 45 min (protected from light), then centrifuged and resuspended in R10. Cells were then incubated with antibodies to CD3 and CD28, and stained with fluorochrome labeled antibodies against CD4 and CD8 for 15 min at room temperature. Cells were washed twice with R10 media and rested for 15 min. Cells were then analyzed on a LSRII flow cytometer for 30 s to establish the baseline Fluo-4 fluoresence. Goat anti-mouse IgG crosslinking antibody (Sigma) was then added and cell analyzed by flow cytometry for 5 min.
Western Blot Protocol Cells were resuspended in R10 media with antibodies to CD3 and CD28 were added to cells on ice for 20 min, washed, then pre-warmed to 37°C. Goat antimouse cross-linking antibodies was then added and incubated at 37°C for 15 min. Cells were were incubated in lysis buffer (150 mM NaCL, 10 mM Tris-base, 10 mM tetrasodium pyrophosphate, 1 % NP-40, 1 mM PMSF, 1 mM NaF, 0.5 EDTA, 2 mM sodium orthovanadate, and 1 μg/ml each of Aprotinin, Pepstatin, and Leupeptin), vortexed thoroughly and incubated on ice for 10 min, then centrifuged at 4°C for 10-15 min at 10,000 rpm and supernatants were collected and frozen until analyzed. Lysates were run on a 4-12 % gradient polyacrylamide gel (Invitrogen), blotted onto PVDF Immobilon-FL (Millipore), blocked with Li-Cor Blocking Solution, then incubated with phospho-tyrosine specific antibody 4G10. Blots were washed then incubated with AlexaFluor-A680 goat anti-mouse IgG antibody, washed, then analyzed with a Li-Cor Odyssey imaging system. Microarray Analysis Microarray analysis was performed in accordance to the manufacturer's protocol. Briefly, purified RNA (~100 ng) was amplified using a two-cycle cDNA synthesis kit, and cRNA was synthesized, labeled, fragmented, and hybridized to the GeneChip human genome U133 plus 2.0 array (Affymetrix). After hybridization arrays were washed and stained with the GeneChip Hybridization Wash and Stain Kit (Affymetrix) and scanned. Image data were quantified with Affymetrix Expression Console Software and normalized with Robust Multichip Analysis (RMA; www.bioconductor.org/) to determine signal log ratios. All raw data files have been deposited in The National Center for Biotechnology Information Gene Expression Omnibus (Accession Number GSE22045).
Results

Isolation of Highly Purified T R Cells
We utilized a sorting strategy to isolate pure populations of human T R cells. PBMCs isolated from random healthy blood donors were first labeled with a CD25-PE antibody, and then isolated with goat anti-mouse labeled magnetic beads by magnetic column separation. Staining of the isolated populations with Foxp3 specific antibody revealed that roughly 42 % of the positively selected cells expressed Foxp3, and these cells correlated with the CD25 hi population (Fig. 1a) . The percent purity of Foxp3 + cells in the CD25 isolated cells varied from 50 % to 95 % depending on the experiment (data not shown). The CD25 selected cells could be sorted based on CD25 hi expression. Staining of pre-and post-sorted populations with Foxp3 antibodies showed an increase in purity of T R cells from approximately 42 % to 95 % following cell sorting in this experiment, with purities over 90 % on average (Fig. 1b) . Similar purities were obtained when cells were sorted based on CD25 and CD127 (data not shown). CD25 hi sorted cells were able to inhibit the proliferation of autologous CD4 cells in coculture assays (data not shown).
Microarray Analysis of Highly Purified Human T R Cells
In order to confirm that our isolation strategy resulted in cells with characteristics of T R cells, we performed gene expression profiling of highly purified T R cells from two different individuals, which were compared to the gene expression profile of naïve CD4 + CD45RA + cells. We first performed hierarchical clustering of the gene expression profiles of unactivated naïve and T R cells from the two individuals. We show that the gene expression patterns of T R cells were highly similar between the two samples (correlation coefficient of 0.82), as were the gene expression profiles of naïve CD4 cells between the two samples (correlation coefficient of 0.91). After averaging the gene expression signal from these two individuals, we compared the gene expression profile of T R cells with naïve CD4 cells and show that T R cells over-express a variety of genes known to be associated with a T R phenotype (e.g. CTLA-4, IKZF2, IL-2RA). In addition, we also detected very high levels of expression of genes not typically associated with a T R phenotype, with the highest level of expression of IL-1 receptors in T R cells (Fig. 2) . These data confirm that the sorting strategy was effective at isolating T cells expressing a T R phenotype.
Monocytes Allow for Activation of Human T R Cells
Using these human T R cells, we first tested if IL-2 was able to overcome the anergic phenotype of these cells. We chose to utilize antibodies to CD3 and the complement regulatory protein CD46 to activate these cells since prior studies have shown that antibodies to CD3 and CD46 are better able to activate human CD4 T cells compared with CD3 and CD28 antibodies [22] . Furthermore, we wanted to be able to control for the amount of IL-2 in this system, and CD46 activating antibodies are not able to provide the necessary co-stimulation required for IL-2 production [22] . Purified T R cells from healthy random donors were stimulated with plate bound antibodies to CD3 and CD46 in the presence or absence of IL-2. As shown in Fig. 3a , T R cells were unable to efficiently proliferate when activated in this manner and increasing the dose of IL-2 was unable to restore proliferation even at doses up to 1000 U/ml (data not shown). Preliminary experiments of CD25 selected, unsorted cells demonstrated efficient proliferation of T R cells in the presence of IL-2, implying that other cell populations in these cultures allowed for T R proliferation (data not shown). These unsorted populations of CD25 + cells did contain monocytes, therefore we tested whether the presence of monocytes was able to overcome the anergic phenotype of pure T R cells. When monocytes were added to the cultures of purified T R cells and activated with antibodies to CD3 and CD46 without added IL-2, little proliferation or IL-10 production was detected (Fig. 3a) . However, when IL-2 was added to these cultures, a significant increase in proliferation and IL-10 production was detected. Since reports have suggested that high dose IL-2 allows for T R cell activation, we tested the dose of IL-2 required to activate T R cells when activated in the presence of monocytes. As shown in Fig. 3b , T R cells were able to proliferate and produce IL-10 in the presence of monocytes even at doses of IL-2 as low as 0.1 U/ml. Thus, in the presence of proper activation conditions, T R cells efficiently utilize IL-2 to proliferate and produce IL-10.
Dendritic Cells Efficiently Activate Human T R Cells, and this Response is Independent of CD80/CD86 Interactions Studies in mice have shown that T R cells exist predominantly in close proximity to dendritic cells in vivo [23] , and other studies have demonstrated expansion of human T R cells when activated in the presence of dendritic cells [24] . Knowing that monocytes were able to stimulate pure human T R cells, we next tested whether dendritic cells (DCs) were able to efficiently activate human T R cells. Human CD14 + monocytes were cultured in the presence of GM-CSF and IL-4 for 3 days to generate immature DCs. In some experiments, LPS was added for 16 h prior to use to generate mature DCs. In addition, to test the contribution of CD80 and CD86 in the activation of T R cells, neutralizing antibodies to CD80 and CD86 were added to some of the cultures. Finally, all data from these experiments were normalized to the proliferation Overexpressed in T R Underexpressed in T R Fig. 2 Gene expression profiling in highly pure human T R cells. Pure T R cells and naïve CD4 cells were isolated by cell sorting, then RNA isolated and microarray analysis performed. Immunologically relevant genes are presented that are preferentially overexpressed or underexpressed in T R cells compared to naïve CD4 cells and IL-10 expression of CD4 + cells in order to compare the proliferative capacity of T R cells to conventional T cells.
As shown in Fig. 4a , when T R cells were activated alone, little proliferation was detected even in the presence of exogenous IL-2. When immature DCs were added to the cultures of T R cells, we saw strong proliferation and IL-10 production of T R cells even in the absence of IL-2 (Fig. 4a) . CD80/CD86 neutralizing antibodies had no effect on the proliferation of T R cells in the presence of immature DCs (Fig. 4, black bars) . These antibodies were able to block the proliferation of naïve CD4 cells activated on LPS stimulated monocytes, demonstrating that they were effective at neutralizing CD80/CD86 mediated signals (data not shown). When LPS matured DCs were utilized, little increase in IL-10 production or proliferation were detected in the absence of IL-2 above that observed with immature DCs. When IL-2 was added to these cultures, proliferation and IL-10 production was enhanced with both immature and mature dendritic cells (Fig. 4b) . Under these conditions, CD80/CD86 blocking antibodies did inhibit the increase in proliferation and IL-10 production. Importantly, the proliferative capacity of pure T R cells was comparable to conventional CD4 cells when LPS matured DCs were added to the cultures in the presence of IL-2, indicating that under the proper activating conditions these cells proliferate and produce anti-inflammatory cytokines efficiently.
Superagonist CD28 Antibodies Allow for Proliferation and IL-10 Production of Human T R Cells
Since CD80/CD86 blocking antibodies did show some effect on T R activation, and since CD28 appears important in T R development in mice, we next tested if signals transmitted by CD28 are able to reverse the anergic phenotype of human T R cells. We tested two different CD28 antibodies (clones 28.2 and 9.3) and compared that with the response to CD46 antibodies. When T R cells were activated alone with antibodies to CD3 and CD46 or CD28 (clone 28.2), no proliferation or IL-10 production was detected (Fig. 5) . However, when T R cells were activated alone with antibodies to CD28 (clone 9.3), a significant increase in proliferation and IL-10 production was detected, although at lower levels than when DCs are present in the cultures. When T R cells were activated in the presence of monocytes, all three antibodies were able to induce the proliferation of human T R cells. Exogenous IL-2 was required for the proliferation and IL-10 production of pure T R cells, indicating that although the CD28 clone 9.3 was able to allow for the proliferation and IL-10 production of human T R cells, it did not allow for IL-2 production from T R cells.
Signal Transduction of Human T R Cells
To further understand the anergic phenotype of pure T R cells, we examined the signal transduction events following TCR activation of T R cells. We examined the phosphotyrosine profile of T R cells, naïve CD4 lymphocytes, and memory CD4 lymphocytes activated with antibodies to CD3 and CD46, or CD3 and CD28 (clone 9.3). As shown in Fig. 6a , human T R cells induced the phosphorylation of numerous proteins in response to CD3/CD46 and CD3/ CD28 (clone 9.3) activating antibodies. Immunoprecipitation with specific antibodies to Zap-70, CD3ζ, and LAT were used to establish the identity of the phosphorylated proteins (data not shown). There was no difference in phosphorylation of Zap-70, CD3ζ, or LAT in T R cells in response to CD3/CD46 activation compared with CD3/ CD28 antibodies despite clear differences in proliferation of T R cells in response to CD3/CD28 (Fig. 5) .
Since human T R cells do not show defects in the phosphorylation of proteins involved in the TCR activation, we next tested whether these cells demonstrated an increase in intracellular calcium following activation with CD3/CD46 or CD3/CD28 (clone 9.3) antibodies and compared this to the response of naïve and memory CD4 cells. When naïve or memory CD4 lymphocytes are activated with antibodies to CD3 and CD46 or CD3 and CD28, a strong increase in intracellular calcium is detected (Fig. 6b) . Naïve lymphocytes stimulated with CD3/CD46 or CD3/CD28 demonstrated a higher prolonged intracellular calcium flux compared with antibodies. Neutralizing antibodies (Ab) to CD80 and CD86 were added (black bars) in some experiments. Three days later proliferation and IL-10 production were measured. All results were normalized to the proliferation and IL-10 production of conventional CD4 + cells activated similarly from each individual experiment. Data presented is the average from 4 separate experiments. *** p0 <0.001, ** p0<0.01, *p0<0.05 when compared to CD25 hi cells activated without other cell populations unless otherwise indicated memory cells. When human T R cells were stimulated with antibodies to CD3/CD46, a detectable but weak increase in intracellular calcium was detected. When stimulated with antibodies to CD3 and CD28, a strong increase in intracellular calcium was detected, but still remained below the maximum calcium level in naïve or memory cells. The level of intracellular calcium appeared to correlate with the proliferative capacity of T R cells.
TGF-β is Required for IL-10 Production but not Proliferation of Human T R Cells
Studies have suggested a close relationship between TGF-β and T R cell function. TGF-β induces Foxp3 expression in human and murine CD4 cells, and the resulting Foxp3 positive cells exhibit suppressive function in murine models [25, 26] , although studies with human cells remain controversial [27] . Other studies suggest that TGF-β is important to maintaining peripheral T R cell numbers and suppressive function [28] . Therefore, we tested the effect of exogenous TGF-β1 as well as the effect of a pan-TGF family neutralizing antibody (clone 1D11) on T R cell proliferation and IL-10 production. When human T R cells are activated with CD3 and CD28 antibodies in the presence of IL-2, proliferation and IL-10 production was detected (Fig. 7) . When TGF-β1 was added to these cultures, proliferation of purified T R cells was inhibited, but IL-10 levels remained elevated. When all TGF-β family members were neutralized, we detected significant proliferation of T R cells, but the expression of the IL-10 was severely decreased. These data indicated that TGF-β is critical to maintaining IL-10 expression in T R cells independent of its effect on proliferation.
Discussion
To better understand the requirements for growth and immunosuppressive cytokine expression of highly pure human T R cells, we developed a novel sorting strategy to isolate human T R to greater than 90 % purity that express functional characteristics of T R cells and a gene expression profile consistent with a T R phenotype. We demonstrate that flow cytometry purified T R cells fail to proliferate or express the immunosuppressive cytokine IL-10, even at high doses of IL-2. Dendritic cells are able provide the necessary signals to induce T R cell proliferation and IL10 production, and under these conditions T R cells are highly sensitive to IL-2, likely due to the constitutive expression of the high affinity IL-2 receptor CD25. Monocytes are less effective than DCs in this regard, although this could be partly explained by the use of a CD14 positive selection strategy that has been shown to affect the costimulatory function of these cells [29] . In addition, IL-2 is critical to IL-10 production and proliferation and under the correct activating conditions, IL-2 drives IL-10 production in a dose dependent manner. Studies have shown that STAT5 is able to induce IL-10 expression due to STAT5 binding to an enhancer element of the IL-10 locus [30] . In addition, studies examining the expression of IL-10 in vivo have shown that T R cells are the predominant IL-10 expressing cell, and one explanation of this observation would be that the high expression of CD25 in T R cells allows for effective utilization of IL-2 to drive IL-10 production [31] . Dendritic cells are the most effective antigen presenting cell that are able to induce T R cell proliferation and IL-10 production, and in the presence of DCs, T R cells are able to proliferate to levels comparable to conventional CD4 cells. Prior studies have shown that signals mediated through CD28 are critical for T R cell development. CD28 −/− animals have significantly reduced numbers of T R cells compared with IL-2 or IL-2 receptor deficient animals [32] . However, neutralizing antibodies to CD80/CD86 were unable to Fig. 7 Role of TGF-β in human T R cells proliferation and IL-10 production. Pure T R cells were cultured in media alone or activated with antibodies to CD3 and CD28, together with 10 U/ml of IL-2 with TGF-β1 (TGF) or the pan-TGF family neutralizing antibody 1D11 (block). Three days later proliferation and IL-10 production was measured abrogate T R activation in the presence of immature DCs, but did attenuate the proliferation of T R cells stimulated in the presence of LPS treated DCs. Although this finding could be explained by technical reasons, such as failure of access of blocking antibodies in an immune synapse, it is also possible that DCs provide other co-stimulatory signals that drive the activation of T R cells. In support of this, CD28 co-stimulation of human T R cells was unable to fully activate these cells compared to the affect of DCs. In addition, unlike monocytes, DCs are able to induce T R cell proliferation and IL-10 production in the absence of exogenous IL-2. Previous reports have shown that DCs express IL-2 [33] [34] [35] [36] , although production of this cytokine is dispensable for effector T cell responses. Whether IL-2 production by dendritic cells is important for T R expansion in vivo remains to be determined.
We also examined the proximal TCR phosphorylation events of pure human T R cells. Our studies did not detect any detectable difference in phosphorylation of proteins in response to TCR activation even though these cells did not proliferate. There was no change in phosphorylation of Zap-70, CD3ζ or LAT in response to CD3 and superagonistic CD28 antibodies, also arguing that defects in proximal signaling proteins does not account for the rescue of proliferation by CD28 antibody (clone 9.3). When intracellular calcium levels were analyzed, we demonstrate that the failure of human T R cells to proliferate to CD3/CD46 antibodies correlated with a failure to increase intracellular calcium levels compared to conventional CD4 memory and naïve CD4 cells. When CD3 and superagonistic CD28 antibodies (clone 9.3) were utilized, human T R cells did display an increase in intracellular calcium, which correlated with the extent of proliferation of T R cells. These data argue that a defect in CD28 signaling pathway at least partially accounts for the anergic phenotype of human T R cells, and that strong stimulation with CD28 agonists is able to partly overcome this defect, which is supported by other studies [37, 38] .
These studies also examined the role of TGF-β on T R cell proliferation and IL-10 production. We demonstrate that TGF-β actually inhibited the proliferation of pure human T R cells. Surprisingly, the addition of TGF-β resulted in high levels of IL-10 to be produced, even though the cells proliferated less, implying that proliferation and IL-10 production in these cells occur due to divergent pathways. When an antibody that neutralizes all TGF-β family members was added to the cultures, proliferation was restored, but IL-10 production was severely inhibited. This is the first data that suggests that one of the main functions of TGF-β in T R cells is to induce the expression of IL-10 separate from the role of TGF-β in inducing the expression of Foxp3. We have shown that blocking TGF-β also blocked the upregulation of Foxp3 in T R cells, although these cells did express baseline levels of Foxp3 (data not shown). TGF-β stimulation of Th1 cells was able to induce the expression of IL-10 that was dependent on Smad4 activation of the IL-10 locus [39] , providing further evidence that one function of TGF-β signaling is to induce IL-10 expression. Collectively, these data indicate that in addition to the role of TGF-β in inducing Foxp3 in CD4 cells and a regulatory phenotype, TGF-β is critical to the expression of IL-10 from human T R cells.
